See more : Orient Group Incorporation (600811.SS) Income Statement Analysis – Financial Results
Complete financial analysis of Merck & Co., Inc. (MRK.PA) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Merck & Co., Inc., a leading company in the Drug Manufacturers – General industry within the Healthcare sector.
You may be interested
- Hang Tai Yue Group Holdings Limited (8081.HK) Income Statement Analysis – Financial Results
- Smurfit Westrock Plc (SWR.L) Income Statement Analysis – Financial Results
- NorthWest Healthcare Properties Real Estate Investment Trust (NWHUF) Income Statement Analysis – Financial Results
- Gold Circuit Electronics Ltd. (2368.TW) Income Statement Analysis – Financial Results
- Photocure ASA (PHCUF) Income Statement Analysis – Financial Results
Merck & Co., Inc. (MRK.PA)
About Merck & Co., Inc.
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 | 1996 | 1995 | 1994 | 1993 | 1992 | 1991 | 1990 | 1989 | 1988 | 1987 | 1986 | 1985 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 60.12B | 59.28B | 48.70B | 47.99B | 46.84B | 42.29B | 40.12B | 39.81B | 39.50B | 42.24B | 44.03B | 47.27B | 48.05B | 45.99B | 27.43B | 23.85B | 24.20B | 22.64B | 22.01B | 22.94B | 22.49B | 51.79B | 47.72B | 40.36B | 32.71B | 26.90B | 23.64B | 19.83B | 16.68B | 14.97B | 10.50B | 9.66B | 8.60B | 7.67B | 6.55B | 5.94B | 5.06B | 4.13B | 3.55B |
| Cost of Revenue | 16.13B | 17.41B | 13.63B | 15.49B | 14.11B | 13.51B | 12.78B | 13.89B | 14.93B | 16.77B | 16.95B | 16.45B | 16.87B | 18.40B | 9.02B | 5.58B | 6.14B | 6.00B | 5.15B | 4.96B | 4.32B | 33.05B | 28.98B | 21.17B | 16.71B | 13.17B | 10.95B | 8.59B | 6.79B | 5.28B | 2.11B | 1.77B | 1.67B | 1.52B | 1.33B | 1.32B | 1.23B | 1.14B | 1.09B |
| Gross Profit | 43.99B | 41.87B | 35.08B | 32.51B | 32.73B | 28.79B | 27.35B | 25.92B | 24.56B | 25.47B | 27.08B | 30.82B | 31.18B | 27.59B | 18.41B | 18.27B | 18.06B | 16.63B | 16.86B | 17.98B | 18.17B | 18.74B | 18.74B | 19.20B | 16.01B | 13.72B | 12.68B | 11.24B | 9.89B | 9.69B | 8.39B | 7.89B | 6.93B | 6.15B | 5.22B | 4.62B | 3.83B | 2.98B | 2.46B |
| Gross Profit Ratio | 73.17% | 70.63% | 72.02% | 67.74% | 69.87% | 68.06% | 68.16% | 65.10% | 62.19% | 60.30% | 61.50% | 65.21% | 64.89% | 60.00% | 67.12% | 76.59% | 74.62% | 73.49% | 76.61% | 78.38% | 80.81% | 36.18% | 39.27% | 47.56% | 48.93% | 51.02% | 53.66% | 56.69% | 59.30% | 64.72% | 79.89% | 81.63% | 80.57% | 80.13% | 79.72% | 77.76% | 75.61% | 72.29% | 69.28% |
| Research & Development | 30.53B | 13.55B | 12.25B | 13.56B | 9.87B | 9.75B | 10.21B | 10.12B | 6.70B | 7.18B | 7.50B | 8.17B | 8.47B | 10.99B | 5.85B | 4.81B | 4.88B | 4.78B | 3.85B | 4.01B | 3.18B | 2.68B | 2.46B | 2.34B | 2.07B | 1.82B | 1.68B | 1.49B | 1.33B | 1.23B | 1.17B | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 7.58B | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 6.22B | 6.17B | 5.20B | 4.51B | 4.30B | 3.84B | 3.30B | 3.18B | 2.91B | 4.07B | 3.56B | 3.24B | 2.76B | 2.55B | 2.25B | 1.75B | 1.33B |
| Selling & Marketing | 2.30B | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 9.83B | 9.76B | 10.31B | 11.61B | 11.91B | 12.78B | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 9.88B | 10.04B | 9.63B | 10.47B | 10.62B | 10.10B | 9.83B | 9.76B | 10.31B | 11.61B | 11.91B | 12.78B | 13.73B | 13.25B | 8.54B | 7.38B | 7.56B | 8.17B | 7.16B | 7.35B | 6.39B | 6.19B | 6.22B | 6.17B | 5.20B | 4.51B | 4.30B | 3.84B | 3.30B | 3.18B | 2.91B | 4.07B | 3.56B | 3.24B | 2.76B | 2.55B | 2.25B | 1.75B | 1.33B |
| Other Expenses | 0.00 | -1.50B | 1.34B | 886.00M | -139.00M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 140.80M | 204.90M | 330.10M | 1.60B | 1.14B | 1.02B | 1.03B | 927.10M | 859.20M | 875.50M | 414.70M | 321.40M | 263.80M | 254.00M | 221.70M | 204.90M | 210.00M | 193.90M | 287.20M |
| Operating Expenses | 40.42B | 23.59B | 21.88B | 24.03B | 20.49B | 19.85B | 20.04B | 19.89B | 17.02B | 18.79B | 19.41B | 20.94B | 22.20B | 24.24B | 14.39B | 12.18B | 12.44B | 12.95B | 11.00B | 11.36B | 9.71B | 9.07B | 9.01B | 10.11B | 8.41B | 7.35B | 7.02B | 6.26B | 5.49B | 5.28B | 4.50B | 4.40B | 3.82B | 3.50B | 2.99B | 2.75B | 2.46B | 1.94B | 1.62B |
| Cost & Expenses | 56.33B | 41.00B | 35.51B | 39.51B | 34.60B | 33.36B | 32.81B | 33.78B | 31.95B | 35.55B | 36.37B | 37.39B | 39.07B | 42.63B | 23.41B | 17.76B | 18.58B | 18.95B | 16.15B | 16.32B | 14.03B | 42.12B | 37.99B | 31.27B | 25.12B | 20.52B | 17.97B | 14.84B | 12.28B | 10.56B | 6.61B | 6.17B | 5.49B | 5.02B | 4.31B | 4.07B | 3.69B | 3.09B | 2.71B |
| Interest Income | 365.00M | 157.00M | 36.00M | 59.00M | 274.00M | 343.00M | 385.00M | 328.00M | 289.00M | 266.00M | 264.00M | 232.00M | 199.00M | 83.00M | 210.20M | 631.00M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Expense | 1.15B | 962.00M | 806.00M | 831.00M | 893.00M | 772.00M | 754.00M | 693.00M | 672.00M | 732.00M | 801.00M | 714.00M | 749.00M | 715.00M | 458.00M | 251.00M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation & Amortization | 3.87B | 3.91B | 3.21B | 3.63B | 3.65B | 4.52B | 4.64B | 5.44B | 6.38B | 6.69B | 6.99B | 6.98B | 7.43B | 7.38B | 2.58B | 1.63B | 1.99B | 2.27B | 1.71B | 1.45B | 1.31B | 1.49B | 1.46B | 1.28B | 1.14B | 1.02B | 1.03B | 927.10M | 859.20M | 875.50M | 414.70M | 321.40M | 263.80M | 254.00M | 221.70M | 204.90M | 210.00M | 193.90M | 182.50M |
| EBITDA | 6.91B | 21.32B | 17.90B | 10.18B | 12.88B | 13.99B | 11.95B | 10.82B | 12.45B | 24.71B | 13.33B | 16.43B | 15.46B | 9.75B | 18.33B | 11.81B | 7.61B | 5.96B | 7.57B | 8.21B | 9.88B | 10.32B | 10.41B | 10.69B | 9.06B | 7.39B | 6.70B | 5.91B | 5.26B | 5.28B | 4.30B | 3.81B | 3.37B | 2.91B | 2.46B | 2.07B | 1.58B | 1.24B | 1.02B |
| EBITDA Ratio | 11.49% | 31.41% | 28.46% | 18.88% | 27.50% | 33.15% | 29.63% | 27.06% | 31.47% | 58.46% | 30.03% | 34.48% | 32.03% | 20.94% | 66.37% | 47.96% | 22.15% | 37.51% | 41.21% | 41.09% | 47.17% | 22.59% | 24.87% | 27.50% | 29.85% | 34.01% | 31.72% | 32.62% | 33.91% | 35.34% | 33.50% | 35.42% | 39.88% | 38.49% | 38.24% | 34.95% | 31.91% | 30.69% | 29.30% |
| Operating Income | 0.00 | 14.71B | 10.65B | 5.44B | 9.23B | 8.93B | 7.31B | 6.03B | 7.55B | 6.68B | 7.67B | 9.88B | 8.98B | 3.36B | 4.02B | 6.09B | 5.62B | 3.69B | 5.86B | 6.62B | 8.46B | 9.67B | 9.73B | 9.09B | 7.59B | 6.38B | 5.67B | 4.98B | 4.40B | 4.41B | 3.89B | 3.49B | 3.11B | 2.65B | 2.24B | 1.87B | 1.37B | 1.04B | 839.80M |
| Operating Income Ratio | 0.00% | 24.81% | 21.86% | 11.33% | 19.70% | 21.12% | 18.22% | 15.15% | 19.11% | 15.82% | 17.41% | 20.90% | 18.68% | 7.30% | 14.66% | 25.52% | 23.22% | 16.29% | 26.62% | 28.87% | 37.61% | 18.67% | 20.39% | 22.52% | 23.21% | 23.70% | 23.97% | 25.14% | 26.40% | 29.43% | 37.01% | 36.13% | 36.15% | 34.56% | 34.14% | 31.43% | 27.05% | 25.22% | 23.67% |
| Total Other Income/Expenses | -1.90B | -2.42B | 289.00M | 1.23B | 3.54B | -903.00M | -788.00M | -840.00M | -2.15B | 10.60B | -2.12B | -1.14B | -1.64B | -1.70B | 11.27B | 3.72B | -2.25B | 2.53B | 1.51B | 1.35B | 594.80M | 545.80M | 674.30M | 735.00M | 1.03B | 1.76B | 795.80M | 556.10M | 393.60M | 10.10M | -783.00M | 72.10M | 57.00M | 47.40M | 46.70M | 4.20M | 36.00M | 32.10M | 17.20M |
| Income Before Tax | 1.89B | 16.44B | 13.88B | 8.79B | 11.46B | 8.70B | 6.52B | 4.66B | 5.40B | 17.28B | 5.55B | 8.74B | 7.33B | 1.65B | 15.29B | 9.81B | 3.37B | 6.22B | 7.36B | 7.97B | 9.05B | 10.21B | 10.40B | 9.82B | 8.62B | 8.13B | 6.46B | 5.54B | 4.80B | 4.42B | 3.10B | 3.56B | 3.17B | 2.70B | 2.28B | 1.87B | 1.41B | 1.07B | 857.00M |
| Income Before Tax Ratio | 3.14% | 27.74% | 28.50% | 18.32% | 24.47% | 20.57% | 16.25% | 11.70% | 13.67% | 40.92% | 12.59% | 18.49% | 15.26% | 3.59% | 55.75% | 41.12% | 13.93% | 27.48% | 33.45% | 34.76% | 40.25% | 19.72% | 21.80% | 24.34% | 26.35% | 30.24% | 27.34% | 27.94% | 28.76% | 29.49% | 29.55% | 36.88% | 36.81% | 35.18% | 34.85% | 31.50% | 27.76% | 25.99% | 24.16% |
| Income Tax Expense | 1.51B | 1.92B | 1.52B | 1.71B | 1.69B | 2.51B | 4.10B | 718.00M | 942.00M | 5.35B | 1.03B | 2.44B | 942.00M | 671.00M | 2.27B | 2.00B | 95.30M | 1.79B | 2.73B | 2.16B | 2.46B | 3.06B | 3.12B | 3.00B | 2.73B | 2.88B | 1.85B | 1.66B | 1.46B | 1.42B | 936.50M | 1.12B | 1.05B | 917.60M | 787.60M | 664.20M | 498.80M | 397.60M | 317.10M |
| Net Income | 365.00M | 14.52B | 13.05B | 7.07B | 9.84B | 6.22B | 2.39B | 3.92B | 4.44B | 11.92B | 4.40B | 6.17B | 6.27B | 861.00M | 12.90B | 7.81B | 3.28B | 4.43B | 4.63B | 5.81B | 6.83B | 7.15B | 7.28B | 6.82B | 5.89B | 5.25B | 4.61B | 3.88B | 3.34B | 3.00B | 2.17B | 1.98B | 2.12B | 1.78B | 1.50B | 1.21B | 906.40M | 675.70M | 539.90M |
| Net Income Ratio | 0.61% | 24.49% | 26.79% | 14.72% | 21.01% | 14.71% | 5.97% | 9.85% | 11.25% | 28.22% | 10.00% | 13.05% | 13.05% | 1.87% | 47.04% | 32.74% | 13.54% | 19.59% | 21.04% | 25.34% | 30.38% | 13.80% | 15.26% | 16.90% | 18.01% | 19.51% | 19.52% | 19.57% | 19.99% | 20.02% | 20.63% | 20.54% | 24.66% | 23.22% | 22.83% | 20.32% | 17.91% | 16.37% | 15.22% |
| EPS | 0.14 | 5.74 | 5.16 | 2.79 | 3.88 | 2.40 | 0.89 | 1.41 | 1.60 | 4.20 | 1.50 | 2.04 | 2.06 | 0.28 | 6.12 | 3.66 | 1.51 | 2.04 | 2.11 | 2.62 | 3.05 | 3.17 | 3.18 | 2.96 | 2.51 | 2.21 | 1.92 | 1.60 | 1.35 | 1.19 | 0.94 | 1.06 | 0.92 | 0.76 | 0.63 | 0.51 | 0.37 | 0.27 | 0.21 |
| EPS Diluted | 0.14 | 5.74 | 5.14 | 2.78 | 3.82 | 2.32 | 0.87 | 1.38 | 1.56 | 4.07 | 1.47 | 2.01 | 2.03 | 0.28 | 5.68 | 3.64 | 1.49 | 2.03 | 2.10 | 2.61 | 3.03 | 3.14 | 3.14 | 2.90 | 2.45 | 2.15 | 1.87 | 1.56 | 1.32 | 1.17 | 0.93 | 1.05 | 0.91 | 0.76 | 0.63 | 0.51 | 0.37 | 0.27 | 0.21 |
| Weighted Avg Shares Out | 2.54B | 2.53B | 2.53B | 2.53B | 2.54B | 2.59B | 2.70B | 2.78B | 2.78B | 2.84B | 2.93B | 3.03B | 3.04B | 3.10B | 2.11B | 2.14B | 2.17B | 2.18B | 2.20B | 2.22B | 2.24B | 2.26B | 2.29B | 2.31B | 2.35B | 2.38B | 2.41B | 2.43B | 2.47B | 2.51B | 2.30B | 1.87B | 2.31B | 2.34B | 2.37B | 2.37B | 2.45B | 2.50B | 2.57B |
| Weighted Avg Shares Out (Dil) | 2.55B | 2.53B | 2.54B | 2.54B | 2.58B | 2.68B | 2.75B | 2.84B | 2.84B | 2.93B | 3.00B | 3.08B | 3.09B | 3.12B | 2.27B | 2.15B | 2.19B | 2.19B | 2.20B | 2.23B | 2.25B | 2.28B | 2.32B | 2.35B | 2.40B | 2.44B | 2.47B | 2.49B | 2.53B | 2.55B | 2.33B | 1.89B | 2.33B | 2.34B | 2.37B | 2.37B | 2.45B | 2.50B | 2.57B |
No news found for: MRK.PA
Source: https://incomestatements.info
Category: Stock Reports